EZH2 and cancer: The regulation of polycomb proteins (PcG), which have the ability to epigenetically silence genes, polycomb group RING finger protein 4 (BMI1) and Enhancer of zeste homolog 2 (EZH2), and the associated cancer progression are potential therapeutic targets.